Assignee
EMERAMED LTD
IE·5 granted patents·5 pending applications·12 citations·filing 2014–2024
Top patents by PatentIndex Score
10 records- 0195US9592209B2Method of supplementing the diet and ameliorating oxidative stressEMERAMED LTD·Filed 2014·Granted Mar 14, 2017·8 cites·14 claims
- 0287US11628151B2N,N-bis-2-mercaptoethyl isophthalamide for the treatment of neurodegenerative diseasesEMERAMED LTD·Filed 2022·Granted Apr 18, 2023·1 cites·10 claims
- 0387US9907787B2Method of supplementing the diet and ameliorating oxidative stressEMERAMED LTD·Filed 2017·Granted Mar 6, 2018·1 cites·12 claims
- 0485US12128017B2N,N-bis-2-mercaptoethyl isophthalamide for the treatment of neurodegenerative diseasesEMERAMED LTD·Filed 2021·Granted Oct 29, 2024·1 cites·13 claims
- 0569US2025325503A1New use of n,n-bis-2-mercaptoethyl isophthalamideEMERAMED LTD·Filed 2024·Application pending·0 cites
- 0664US9782368B2Use of N,N-bis-2-mercaptoethyl isophthalamideEMERAMED LTD·Filed 2015·Granted Oct 10, 2017·1 cites·11 claims
- 0762US2018250247A1N,n-bis-2-mercaptoethyl isophthalamide for the treatment of neurodegenerative diseasesEMERAMED LTD·Filed 2017·Application pending·0 cites
- 0856US2017202791A1N,n-bis-2-mercaptoethyl isophthalamide for the treatment of neurodegenerative diseasesEMERAMED LTD·Filed 2015·Application pending·0 cites
- 0947US2023181498A1New use of n,n-bis-2-mercaptoethyl isophthalamideEMERAMED LTD·Filed 2021·Application pending·0 cites
- 1043US2019240173A1New use of n,n-bis-2-mercaptoethyl isophthalamideEMERAMED LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EMERAMED LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →